Nicotinic acetylcholine receptor subunit alpha 1 at neuromuscular junction (nAChR α1)

The nicotinic acetylcholine receptor subunit alpha 1 is the principal acetylcholine-binding subunit of the muscle-type nicotinic receptor, which is a pentameric ligand-gated ion channel located at the neuromuscular junction. The receptor comprises two identical α1 subunits, each contributing to the acetylcholine binding sites, along with β1, δ, and either γ (fetal) or ε (adult) subunits. Binding of acetylcholine to these α1 subunits induces a conformational change that opens the central pore, allowing Na⁺, K⁺, and (to a lesser extent) Ca²⁺ ions to flow across the muscle cell membrane, triggering endplate depolarization and subsequent muscle contraction. This receptor is the molecular target for many clinically used neuromuscular blockers, is pathologically targeted in autoimmune and genetic neuromuscular diseases, and its function is critical for voluntary movement and muscle strength.

Other names

Acetylcholine receptor subunit alpha 1nAChR α1Nicotinic acetylcholine receptor α1 subunitAlpha-1 subunit of muscle nAChRCHRNA1 (gene name)Fetal or adult muscle nicotinic acetylcholine receptor α1 (depending on developmental stage)

Competitive antagonism (muscle relaxants, e.g., vecuronium block ACh binding at α1 sites) Depolarizing block (succinylcholine activates and then desensitizes channel, causing sustained depolarization) Irreversible antagonism (α-bungarotoxin binds tightly to α1 subunits, blocking activity) Indirect potentiation (acetylcholinesterase inhibitors increase ACh availability at receptor)